Increase transparency in prescription drug prices.

Janice D. Schakowsky · Illinois · Democratic

oversight impact 0.55 specificity 0.70 extraction confidence 86%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

increase transparency in prescription drug prices

Schakowsky supported drug-pricing transparency measures, including public disclosure of drug discounts and expanded access to drug rebate and payment data.

CREC-2019-10-28-house.pdf
secondary · other · model gpt-5.5

Evidence

legacy_unverified · Source version not recorded · locator unknown

The homepage's Latest News feed shows June 9, June 5, and May 21, 2026 items on other topics; no prescription-drug-price transparency update appears in the current feed.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): No concrete sign of new action on prescription drug price transparency in the 2026-06-15 to 2026-06-17 lookback window; the official site's current news feed is focused on other issues.

unresolved same_term

Congresswoman Jan Schakowsky |Representing the 9th District of Illinois
primary · model gpt-5.4-mini · confidence 61%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved. unknown

The provided evidence only shows that Schakowsky's current site/news feed did not surface a recent prescription-drug-price transparency update in the 2026-06-15 to 2026-06-17 lookback window. That is not enough to confirm the promise was delivered, nor enough to conclude a failed serious attempt, so the safest adjudication is unresolved.

provider codex_cli · model gpt-5.4-mini · confidence 61%